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Stimulation of growth factor signaling has been impli-
cated in the development of invasive phenotype and
p21-activated kinase (PAK1) activation in human breast
epithelial cancer cells. To further explore the roles of
PAK1 in the invasive behavior of breast cancer cells, in
the present study we investigated the influence of inhi-
bition of PAK1 activity on the reorganization of cy-
toskeleton components that control motility and inva-
siveness of cells, using a highly invasive breast cancer
MDA-MB435 as a model system. Our results demonstrate
that overexpression of a kinase dead K299R PAK1 mu-
tant leads to suppression of motile phenotypes as well as
invasiveness of cells both in the absence or presence of
exogenous heregulin-b1. In addition, these phenotypic
changes were accompanied by a blockade of disassem-
bly of focal adhesion points, stabilization of stress fibers,
and enhanced cell spreading and were dependent on the
presence of the kinase dead domain but independent of
the presence of the Rac/cdc42 intact (Cdc42/Rac interac-
tive binding) domain of PAK1. We also demonstrated
that in K299R PAK1-expressing cells, F-actin filaments
were stabilized by persistent co-localization with the
actin-binding proteins tropomyosin and caldesmon. Ex-
tension of these studies to invasive breast cancer MDA-
MB231 cells illustrated that conditional expression of
kinase-defective K299R PAK1 was also accompanied by
persistent cell spreading, multiple focal adhesion
points, and reduced invasiveness. Furthermore, inhibi-
tion of PAK1 activity in breast cancer cells was associ-
ated with a reduction in c-Jun N-terminal kinase activ-
ity, inhibition of DNA binding activity of transcription
factor AP-1, and suppression of in vivo transcription
driven by AP-1 promoter (known to be involved in
breast cancer invasion). These findings suggest that
PAK1 downstream pathways have a role in the develop-
ment and maintenance of invasive phenotypes in breast
cancer cells.
Breast cancer is one of the most common malignancies in the
United States, affecting one in nine women. Localized breast
cancer prior to metastasis can be cured by surgery. The high
mortality rate associated with breast cancer, however, is re-
lated to its ability to metastasize beyond the mammary gland
and invade distant sites while the primary tumor is small and
undetected. Thus, tumor cell migration/invasion is an impor-
tant factor in formation of solid tumors and is necessary for
their spread to distinct organs. The process of malignancy
requires, among other steps, changes in growth factor path-
ways and increased migration. The exposure of cells to growth
factors has been shown to cause cytoskeleton reorganization,
formation of lamellipodia, membrane ruffling, and altered cell
morphology, and accordingly, such exposure is implicated in
stimulating cell migration and invasion (1). Most eukaryotic
cells possess the capacity to move over or through a substrate,
and cell migration plays a key role in both normal physiology
and in a disease setting, including invasion and metastasis (2).
In many tissues, the motility function of cells is normally
repressed but can be activated by appropriate stimuli, onco-
genic transformation, or both. In fact, one of the earliest re-
sponses of cells to many extracellular growth factors is rapid
reorganization of their cytoskeleton and cell shape. The leading
edge of a motile cell is composed of thin protrusions of mem-
brane that continuously extend and retract mediating the ini-
tial stage of cell movement and determining the direction of
advance. The underlying cytoskeleton of a leading edge is com-
posed of actin-filament bundles (in filopodia) or meshworks (in
lamellipodia) oriented toward the membrane (3). Cell migra-
tion also involves changes in cytoskeleton actin stress fibers
that end in focal adhesions, which are places where the plasma
membrane is attached to the substratum. Focal adhesions are
specialized sites of adhesion for cells in culture associated with
well defined actin stress fibers, and they represent the link
between the outside extracellular matrix components and the
cytoplasmic integrins coupled with cytoskeletal proteins. Nu-
merous proteins involved in signal transduction are known to
be concentrated at these sites. According to a recent model,
intracellular components of the focal adhesion complex and
actin filaments associate with integrins upon integrin engage-
ment with the extracellular matrix. In the presence of active
Rho, these complexes and actin cluster together by actin-myo-
sin contraction, which leads to focal adhesion and stress fiber
formation. The focal adhesion points play an important role in
the regulation of cell motility, which involves cyclic formation
of cell adhesion and disassembly of actin filaments and focal
adhesion complexes (1).
The small GTPases, including Cdc42, Rac1, and RhoA, have
been implicated in the regulation of morphology, the formation
of filopodia/lamellopodia, membrane ruffles, and stress fibers,
and motility of mammalian cells (1). More specifically, Rac1
induces cortical actin polymerization seen as the process of
membrane ruffling and lamellipodia (4). RhoA induces stress
fiber formation possibly by catalyzing the formation of focal
adhesion (5), and cdc42 induces the formation of peripheral
actin microspikes and filopodia (6). With regard to the mecha-
nism by which the small GTPases initiate and regulate the
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formation of cytoskeletal structures, recently a family of serine/
theonine kinases known as p21-activated kinases (PAKs)1 have
been identified as GTPase targets (7). Activation of PAK1 has
been shown to result in phenotypic changes reminiscent of
those produced by GTPases. If activated either by overexpres-
sion of dominant active PAK1 mutants or by stimulation of
cells with growth factors, PAK1 causes the accumulation of
F-actin and the formation of lamellipodia and filopodia. Fur-
thermore, activated PAK1 has been also shown to be co-local-
ized with F-actin at the leading edge of the cells (7, 8). Activa-
tion of PAK1 has been shown to be accompanied by the
disassembly of stress fibers and focal adhesion complexes (9),
both of which are widely believed to be required for increased
motility. Because PAK1 is a downstream target of cdc42 and
Rac1, which are known to activate extracellular signal-regu-
lated kinase, JNK, p38 kinases, and the transcription factor
nuclear factor-kB (10–12), it has been proposed that PAK1 or a
related kinase may mediate the actions of cdc42 and Rac1.
Indeed, PAK1 has been shown to activate JNK and extracellu-
lar signal-regulated kinase kinases (13, 14). Invasion of T-
lymphocytes and fibroblast has been shown to involve activated
Rac1 and Tiam-1 (15), a Rac1 exchange factor. In addition to
the PAK1-JNK pathway, other effectors for Rac1 such as POR1
have also been implicated in actin rearrangements (16, 17).
Using well differentiated mammary breast cancer cells Keely et
al. (17) showed that PAK1 as well as JNK1 activities are not
required to induce motility and invasion in cells that are over-
expressing active mutants of Rac1. These studies dissociate
Cdc42 and Rac1-induced actin polymerization (ruffles forma-
tion) from PAK and JNK activation, raising the possibility of
existence of a divergent pathway, which involves another Rac1
effector, POR1. It was shown that Rac1 mutants that are ca-
pable of binding PAK1 but not POR1 (and thus activate JNK)
are also able to induce a motile phenotytpe in these cells (16).
However, the same Rac mutants behave in an opposite manner
when used in different cell systems (17).
It is increasingly accepted that alterations in the reorgani-
zation and stability of actin filaments may contribute to in-
creased cell migration and to cell transformation, anchorage-
independent growth, and invasiveness. Tropomyosin (TM) and
caldesmon (CaD) are two essential proteins required for the
reorganization of the actin cytoskeleton mediated by stabiliza-
tion of microfilaments (18, 19). Although TM was initially
discovered as a helical protein that binds to actin grooves in
muscle, it is now clear that Ca21-dependent contractility in
nonmuscle cells is also controlled by TM in conjunction with
CaD (20). CaD is an actin- and calmodulin-binding protein that
is distributed at intervals along stress fibers (18, 21). Recent
studies have shown relationships between 1) overexpression of
CaD and the stabilization of actin microfilament bundles by
enhancing the half-life of TM (22); 2) suppression of TM1 and
the anchorage-independent growth of hamster embryo cells
(23); 3) modulation of the TM isoforms and tumorigenic trans-
formation (24, 25); and 4) CaD/v-erbB interaction and actin
stress fiber disassembly (26). Despite the widely acknowledged
roles of TM and CaD on one hand and PAK1 on the other hand
in actin stabilization, the potential relationship between these
cytoskeleton regulators and invasiveness remains elusive.
Recently, we showed that stimulation of a noninvasive hu-
man breast cancer cell by heregulin leads to the activation of
PAK1 kinases, redistribution of PAK1 at the leading edges of
cells, development of lamellipodia/filopodia and stress fibers,
and increased invasiveness of breast cancer cells (27). To fur-
ther explore the role of PAK1 in the invasive behavior of breast
cancer cells, in this study we investigated the influence of
suppression of the PAK1 activity on the reorganization of cy-
toskeleton components that control motility and in vitro inva-
siveness of cells using the highly invasive MDA-MB435 and
MDA-MB231 breast cancer cell model systems. Our results
demonstrated that overexpression of catalytically defective
K299R PAK1 leads to biogenesis of stable focal adhesions and
stress fibers with matrix-independent enhanced cell attach-
ment and spreading properties. All these biological effects were
dependent on the presence of the kinase defective site and
independent on the presence of an intact Rac/cdc42 binding
domain. In addition, these phenotypic changes were accompa-
nied by persistent suppression of JNK activity, DNA binding
activity of transcription factor AP-1, and in vivo transcription
driven by collagenase promoter. These findings suggest that
the PAK1-dependent pathway have a role in the maintenance
of invasive behavior of breast cancer cells.
MATERIALS AND METHODS
Cell Cultures and DNA Transfection—MDA-MB435 and MDA-
MB231 cells and their PAK1 clones were maintained in DMEM/F12
(1:1) supplemented with 10% tetracycline-free FCS (CLONTECH). To
generate stable MDA-MB435 clones overexpressing K299R PAK-1 mu-
tant, the cells were trypsinized and resuspended at 2 3 107 cells/ml in
DMEM/F-12 supplemented with 10% FCS, and 20 mg of each of the
plasmids (CMV, pCMV6myc-hPAK1k299R) were introduced by electro-
poration (7, 28). Positive clones were selected by adding 400 mg/ml of
Hygromycin for a period of 2–3 months. To generate MDA-MB231 cells
overexpressing tetracycline-regulated hPAK-1k299R, cells were sequen-
tially transfected with ptet-tTak 1 pNeomycin plasmid (pNeo) and
pTet-Splice-HA-PAK1 (K299R) plus Hygromycin plasmid. Forty-eight
hours posttransfection, the cells were selected in medium containing
800 mg of neomycin (to retain the tetracycline-VP16 transactivator), 300
mg/ml hygromycin (to select for the K299R PAK1-regulated expression
vector), and 1 mg/ml tetracycline (to repress transgene expression dur-
ing selection). Clonal cell lines were isolated and expanded and at least
24 clonal lines were examined for inducible transgene expression by
anti-HA immunoblot. These clones express N-terminal HA-tagged
PAK1 K299R when cells are grown in the absence of tetracycline or its
derivative doxycyclin. For transient transfection assays, MDA-435 cells
were plated on coverslips in 6-well plates using DMEM/F12 supple-
mented with 10% FCS and allowed to attach for 12 h. Transient trans-
fections were performed using Fugene 6 kit according to the manufac-
turer’s instruction (Roche Molecular Biochemicals). The ratio DNA/
Fugene-6 used was 3 mg/6 ml, and each PAK1 DNA (1 mg) construct used
was co-transfected with an equal amount of the green fluorescence
protein (GFP) DNA. The following additional constructs were used:
CRIB domain mutant pCMV-cMyc-(L83, L86), CRIB and kinase domain
mutant pCMV-cMyc-(L83,L86,K299R), kinase active mutant pCMV-
cMyc-(T423E), and PAK kinase autoinhibitory domain mutant pCMV-
cMyc(PAK 83–149) (7). Transfected cells were identified by green fluo-
rescence and immunostained with an anti-Myc-monoclonal antibody.
Antibodies—Anti-HA antibody and anti-Myc monoclonal antibody
were obtained from the Medical Biomedical Laboratories and Neomar-
kers, respectively. Antibodies against activated JNK, against total
JNK, and PAK-1 were purchased from Santa Cruz Biotechnology.
Monoclonal antibodies against vinculin, caldesmon, and tropomyosin
were from Sigma. Fluorochrome-conjugated goat anti-mouse and anti-
rabbit antibodies were purchased from Molecular Probes.
Reporter Gene Assay—Luciferase fusion plasmids, 270 collagenase
promoter containing a functional AP-1 binding site (270 Col-luc) and
260 collagenase promoter containing deletion of AP-1 binding site (260
Col-luc) were generously provided by Dr. F. X. Claret (29). Cells were
transiently transfected using the FUGENE-6 transfection reagent accord-
ing the manufacturer’s protocol (Roche Molecular Biochemicals). Trans-
fections were carried out in 6-well plates using 2 mg of DNA and 105 cells.
Transfection efficiency was monitored by co-transfaction of b-galactosid-
ase. After 36 h, cells were lysed using a Luciferase assay kit (Promega),
and luciferase activity was measured using a Lumant Luminometer.
Cell Extracts, Immunoblotting, and Immunoprecipitation—Cells
1 The abbreviations used are: PAK, p21-activated kinase; JNK, c-Jun
N-terminal kinase; TM, tropomyosin; CaD, caldesmon; DMEM, Dulbec-
co’s modified Eagle’s medium; FCS, fetal calf serum; HA, hemaggluti-
nin; GFP, green fluorescence protein; CRIB, Cdc42/Rac interactive
binding; HRG, heregulin b1; CMV, cytomegalovirus; AP, activation
protein.
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were lysed in Nonidet P-40 lysis buffer (50 mM Tris-HCl, pH 8.0, 137 mM
NaCl, 10% glycerol, 1% Nonidet P-40, 50 mM NaF, 10 mM b-glycerol
phosphate) containing 1 mM sodium vanadate, 1 mM phenylmethylsul-
phonyl fluoride, and 10 mg/ml apoptinin. Cell extracts were separated
on a 10% SDS-polyacrylamide gel electrophoresis and transferred to
Immobilon membranes. Membranes were blocked with bovine serum
albumin or fat-free milk and probed with the appropriate antibodies
using ECL or alkaline phosphatase-based color methods (27).
Protein Kinase Assays—For PAK1 kinase assay, PAK1 was immu-
noprecipitated from total lysates using PAK1 antibody (Santa Cruz
Biotechnology), and an in vitro kinase reaction was performed using
myelin basic protein as a substrate as described earlier (27). The JNK
kinase activity was determined using a JNK kinase assay kit from New
England Biolabs according to the manufacturer’s protocol. Reaction
products were resolved on a 12% SDS-polyacrylamide gel electrophore-
sis, autoradiographed, and developed using a phosphoimager.
Electrophoretic Mobility Shift Assay—Nuclear extracts were pre-
pared as described (30). AP-1 consensus oligonucleotide (59-cgcttgat-
gactcagccggaa-39) was purchased from Santa Cruz Biotechnology and
end-labeled with 32P using DNA labeling kit (Roche Molecular Bio-
chemicals). An equal amount (10 mg) of nuclear protein was incubated
with labeled AP-1 probe, and DNA binding activity was determined by
electrophoretic mobility shift assay.
Immunofluorescence—Cells cultured on uncoated, matrigel-, colla-
gen-, polylysine- or fibronectin-coated 8-well chamber slides (Falcon)
were fixed with 3.7% paraformaldehyde followed by incubation with
chilled cold acetone for 2 min, washed with phosphate-buffered saline,
blocked, and incubated with the respective primary antibodies for 1 h.
For filamentous actin staining, 0.1 mM Alexa 568-conjugated phalloidin
was included during incubation with the secondary antibody. Slides
were mounted using the Slow Fade Antifade kit (Molecular Probes).
Cells were viewed with an inverted Zeiss Axioplan fluorescence micro-
scope with a charged-coupled device camera using the IP-Lab Spectrum
software, and in some experiments slides were analyzed by confocal
microscopy. In the transient transfection assays the cells that inte-
grated the PAK1 construct were identified by their expression of GFP in
vivo as well as after fixation in paraformaldehyde/acetone and co-
stained for vinculin, F-actin, or Myc-tag followed, where it was the case,
by their detection using the goat anti-mouse Alexa 546-labeled second-
ary antibody.
Migration Assays—To measure the migration potential of MDA-
MB231 cells with the K299R PAK1 mutant under the Tet-off system
(MDA-MB-231/T3 cells), PAK1 expression was induced by culturing in
doxycyclin-free DMEM/F-12 medium plus 10% FCS for 24 h. Cells
grown in the presence of doxycyclin were used as control. After a short
treatment with trypsin, the cells were washed in the presence of soy-
bean trypsin inhibitor, resuspended in DMEM/F12 plus 0.1% bovine
serum albumin in the presence or absence of doxycyclin, and loaded on
the upper well of a Boyden chamber at a concentration of 20,000
cells/well. The lower side of the separating filter was coated with a thick
layer of 1/2 diluted Matrigel (Life Technologies, Inc.) in serum-free
DMEM/F-12. The number of cells that successfully migrated through
the filter and invaded the 2-mm Matrigel layer in order to spread, as
well as those that remained on the upper side of the filter, were counted
by confocal microscopy after staining with propidium iodide (Sigma).
MDA-MB435 clones were assayed for their invasive potential in the
absence or presence of HRG using same thick layer Matrigel-coating
method. Results were expressed as percentages of migrated cells and
compared with the total number of cells (cells present in all Z-sections).
Immunofluorescence and Laser Scanning Confocal Microscopy were
essentially performed as described (27).
RESULTS
Characterization of MDA-MB435 Clones Expressing PAK1
Mutants—Because PAK1 activation has been shown to be closely
linked with the heregulin-induced invasiveness of well differen-
tiated estrogen receptor positive epithelial breast cancer cells
(27), we asked the question if the PAK1 activity is also required
for the maintenance of the invasive phenotype in cell lines with a
different background such as MDA-MB435 and MDA-MB231
(estrogen receptor negative and vimentin positive).
MDA-MB435 cells were stably transfected with kinase dead
K299R PAK1 or with control CMV vector. We isolated three
transfectants expressing 6–10 times higher levels of PAK1
than the levels seen in vector-transfected or in parental cells,
as judged by the differences in the expression of Myc-tagged
K299R PAK1 mutant and endogenous PAK1 (Fig. 1A). To see
FIG. 1. Characterization of MDA-MB435 cells overexpressing K299R PAK1 mutant. A, expression of Myc-tagged PAK1 mutant. Parental
MDA-MB435 and vector-transfected MDA-MB435-CMV cells, MDA-MB435-K5, MDA-MB435-K16, and MDA-MB435-K17, represent three proto-
type clones expressing the c-Myc-tagged PAK1 protein. B, PAK1 immunoprecipitates from total cell lysates were assayed for kinase activity using
myelin basic protein as a substrate. C, cell migration potential was assayed using matrigel-coated Boyden diffusion chambers. Results represent
cell counts of 10 different microscopic fields of three different wells, as detailed under “Materials and Methods.” D, cells grown on matrigel-coated
coverslips were cultured in serum-deprived DMEM/F12 and fixed after 12 h. Representative examples of the distribution of F-actin-specific Alexa
564-phalloidin staining followed by confocal microscopy analysis are shown.
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whether or not the introduced K299R PAK1 gene product had
a significant impact on the kinase activity of the total PAK1
expressed by the transfectants, PAK1 was immunoprecipitated
and subjected to in vitro kinase assay using the myelin basic
protein as a substrate (Fig. 1B). All three kinase dead PAK1
clones (k-clones) exhibited a significant reduction in the level of
PAK1 kinase activity, as compared with the control cells (Fig.
1B, last two lanes).
Effect of Kinase Dead K299R PAK1 on the Invasive Potential
of Breast Cancer Cells—To explore the effect of K299R PAK1
overexpression on the invasiveness of MDA-MB435 cells, we
evaluated the ability of k-PAK1 clones to transmigrate through
a porous filter containing 8-mm pores and coated with Matrigel.
In this Boyden chamber invasion assay, cells that invaded the
Matrigel and reattached to the lower side of the membrane
were quantitated by confocal scanning microscopy. As a con-
trol, the same number of parental MDA-MB435 or mock-trans-
fected cells were plated and counted in the same way. As
illustrated in Fig. 1C, overexpression of kinase dead PAK1
resulted in about a 3-fold reduction in the ability of the cells to
invade through the Matrigel compared with control cells. This
was true for all three K299R PAK1 clones. HRG did not have
an enhancing effect on the invasiveness of K299R PAK1 clones.
As a positive control, we used HRG-stimulated control cells
(Fig. 1C). Although expression of kinase dead PAK1 suppressed
invasiveness of three separate clones, we used the K17 clone in
our subsequent experiments.
To define the effect of the K299R PAK1 mutant on the
motility of MDA-MB435 cells, next we examined the status of
ruffle formation, an essential component of invasive phenotype,
using confocal scanning microscopy. All three K299R PAK1
expressing clones exhibited similar morphological alterations
when plated on plastic plates. K299R PAK1 transfectants de-
velop elongated membrane protrusions without any cell polar-
ity in contrast to parental cells that showed a typical bipolar
morphology similar to fibroblasts (data not shown). Despite the
development of membrane extensions, the K299R PAK1 trans-
fectants acquired a flatter morphology and occupied roughly
twice as much area as parental cells. A flatter morphology was
also evident when transfectants were allowed to attach on a
Matrigel layer. Representative fields of two K299R PAK1
transfectants (K5 and K17) were plated in these conditions and
stained with phalloidin; they showed reduced thickening of the
cell border corresponding to F-actin-containing structures as
compared with parental or mock-transfected cells (Fig. 1D).
Focal Complex Localization of Kinase Dead K299R PAK1
Protein—To understand the impact of PAK1 inactivation on
the potential reorganization of the actin cytoskeleton, we ex-
amined the distribution of F-actin by phalloidin staining and
also confirmed the expression of Myc-tagged PAK1. Overex-
pression of kinase dead PAK1 led to the development of stress
fibers that contain thick F-actin cables connecting the ventral
part of the cells to the substrate (Fig. 2, B, D, and F). The
F-actin cables in the parental cells were thin and disposed
mostly along the longer axis of the cells (Fig. 2, A, C, and E). A
second morphological alteration caused by kinase dead PAK1
expression was the formation of mature focal adhesion contacts
independent of the type of extracellular matrix used such as:
diffusible components from 10% FCS (Fig. 2B), collagen I (Fig.
2F), or fibronectin (Fig. 2D). Surprisingly, these well defined
focal adhesion complexes also contained exogenously expressed
K299R PAK1 protein (Fig. 3B, arrows). Parental cells showed
exclusively cytoplasmic localization for the c-Myc-tag antibody
because of endogenous c-Myc immunoreactivity and represents
the background staining (Fig. 3D) and no co-localization with
focal points (Fig. 3E, arrowheads). The cellular distribution of
the K299R PAK1 was maintained even when cells were plated
on other components of the extracellular matrix such as fi-
bronectin or collagen I (not shown).
Cell Spreading, Enhanced Focal Adhesion Point Numbers,
and Stress Fiber Formations Are Not because of Rac1/cdc42
Sequestration by the CRIB Domain of the K299R PAK1—Block-
ing the functions of Rac-1 or cdc42 or both could mimic the
observed K299R PAK1-associated cellular modifications de-
scribed above. Because the K299R PAK1 construct has an
intact CRIB domain, it is possible that the observed changes in
K299R PAK1 expressing cells could be because of sequestration
of Rac/cdc42. To address this possibility, we have used the
following additional PAK1 mutants: PAK1 double mutant
(H83, 86L, K299R), which has mutations in the GTP binding
and PAK kinase domains; PAK autoinhibitory domain (PAK1–
83-149), which binds and inhibits the endogenous PAK; a con-
stitutively active (T423E) PAK1 kinase; and GTP binding de-
fective (H83, 86L) but kinase active PAK1 (Fig. 4A). To
visualize the effects of these PAK1 mutants, cells were co-
transfected with each one of the PAK1 constructs and an equal
amount of GFP vector. The green fluorescent positive live cells
were monitored for their spreading at different time intervals
after transfection. In Fig. 4A representative microscopic fields
after 6 h posttransfection are presented. Cells transfected with
FIG. 2. MDA-MB435 cells overexpressing K299R PAK1 form
organized focal contacts and stress fibers in different extracel-
lular matrixs. Cells cultured on uncoated (A and B), fibronectin- (C
and D), or collagen- (E and F) coated chamber slides were fixed after 6 h
and co-stained by indirect immunofluorescence for vinculin and F-actin
using Alexa 564-phalloidin. Representative examples of vinculin and
F-actin distributions in MDA-MB435-K17 (B, D, and F) or in MDA-
MB435-CMV (A, C, and E) are shown.
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control vector or kinase active T423E and PAK1 H83, 86L
PAK1 mutants exhibited a bipolar shape (Fig. 4B). In contrast,
cells transfected with kinase defective PAK1 mutants with or
without intact CRIB domain were nonpolar and well spread out
(Fig. 4B). Similar morphological alterations, but to a lesser
degree, were also recorded in cells transfected with PAK83–
149, a known inhibitor of endogenous PAK1 (31, 32). The in-
fluence of different PAK1 mutants on the motility of MDA-MB-
435 cells was evaluated by the Boyden diffusion chamber
assay. Cells were transiently co-transfected with GFP vector
and PAK1 construct(s) and seeded in the upper chamber, and
GFP positive cells were counted on both sides of the porous
filter. As shown in Fig. 4C, transfection of kinase dead K299R
and H83, 86L-K299R PAK1 constructs significantly suppressed
the migration of MDA-MB-435 cells as compared with vector or
T423E PAK1-transfected cells.
In addition to morphological changes, we have also examined
the influence of PAK1 mutants on cell spreading and F-actin
distribution. Cells transfected with K299R or H83, 86L-K299R
PAK1 exhibited increased cell spreading and the appearance of
thick F-actin cables (Fig. 5) and enhanced the number of focal
points (data not shown). Interestingly, cells expressing kinase
active T423E or H83, 86L PAK1 showed significantly less F-
actin polymerization and the absence of stress fibers (Fig. 5).
Staining with c-Myc antibody confirmed that the GFP positive
cells also overexpressed c-Myc (data not shown). Taken to-
gether, these results suggested that the inhibition of PAK1
kinase activity rather than sequestration of the small GTPase
may be the cause of the phenotypic changes shown in the
present study, including increased actin polymerization and
formation of focal points.
HRG Stimulation Failed to Promote Focal Adhesion Disso-
lution in Kinase Dead PAK1 Clones—To see whether the ob-
served anti-invasive effect of the K299R PAK1 mutant was
responsible for the formation of more stable focal adhesion
complexes, we tested the effect of HRG on the dynamics of
F-actin and focal adhesion complexes. As shown in Fig. 6,
actin-containing stress fibers and vinculin-containing focal
complexes were not modified by 1 h treatment with HRG in
cells bearing the kinase dead mutant K299R PAK1 (Fig. 6, A
and C). In contrast, control parental cells exhibited a dramatic
change in the redistribution of F-actin by forming thin polar
protrusions at the cell periphery corresponding to filopodia asso-
ciated with a significant dissolution of the stress fibers (Fig. 6, B
and D, arrowheads). These results suggested that PAK1 activity
is required for focal point dissolution induced by HRG.
Effect of K299R PAK1 on the Reorganization of Actin-stabi-
lizing Proteins—Because PAK1 inactivation was accompanied
by increased persistence of stress fiber cables, we examined the
possibility of the association of actin filaments with actin-
stabilizing proteins such as TM and CaD (21, 33). The K299R
PAK1 transfectants were spread out, contained focal complexes
with thick actin cables, and exhibited co-localization of TM
(Fig. 7, A and A’), whereas the control cells had a fibroblast-like
shape and a diffuse TM distribution. (Fig. 7, B and B’). Another
actin-binding protein, CaD, showed also a fibrilar pattern being
deposited on the stress fibers as evidenced by the appearance of
the yellow color because of co-localization of F-actin and CaD
FIG. 3. Effect of K299R PAK1 on focal adhesion complexes
distribution. MDA-MB435-K17 cells cultured in chamber slides were
kept in DMEM/F-12 supplemented with 10% FCS, fixed after 12 h, and
co-stained for c-Myc tag and F-actin. Arrows (A and B) show fluorescein
isothiocyanate-immunostaining representative examples of focal con-
tacts distribution of c-Myc-tagged PAK1. Co-localization of c-Myc tag
with F-actin is also shown by appearance of the yellow color (A), which
corresponds to the focal points (C, arrows). Diffuse cytoplasmic immu-
noreactivity with anti-Myc antibody corresponding to the endogenous
c-Myc in control cells (D–F) and no co-localization with F-actin in the
focal points was detected in these cells (compare D with A, arrowheads).
FIG. 4. Effect of PAK1 mutants on
the cell shape and migration. A, sche-
matic representation of the constructs
used in the study. B, MDA-MB435 cells
co-transfected with various PAK-1 mu-
tants and/or a GFP vector were photo-
graphed using a computer-based imaging
system (Olympus 1 3 70) set for green
fluorescence light. C, cells were co-trans-
fected with vector or one of three PAK1
mutants and a GFP-containing vector and
plated on the upper side of the filter mem-
brane and allowed to migrate for 24 h
toward the lower side of the filter and to
invade the matrigel. The number of GFP
positive cells that invaded the filter was
expressed as a percentage of the total
GFP positive cells in the same micro-
scopic field. At least 10 fields/membrane
were counted. Each experiment was done
in triplicate. PBD, protein binding domain.
PAK1 Regulation of Invasion 12045
 by guest on M
arch 28, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
(Fig. 7, C and C’). By contrast, CaD staining in mock-trans-
fected cells showed diffuse cytoplasmic distribution (Fig. 7, D
and D’). Interestingly, a closer examination of the focal adhe-
sion structures in some K299R PAK1-expressing cells showed
that there was a loop-like disposition of actin-bound CaD in the
vicinity of the well defined focal points, and these structures
(Fig. 7G, arrowheads) were completely missing in control cells
(Fig. 7H).
Regulation of Breast Cancer Invasion by Conditional Expres-
sion of K299R PAK1—To investigate if the morphological
changes found in stable transfected cell lines were not because
of the long term adaptation during cell culturing, thus related
to an indirect effect of transfected K299R PAK1 gene, we gen-
erated another model, MDA-MB231, in which the expression of
HA-tagged K299R PAK1 protein could be conditionally regu-
lated via a Tet-off regulatory system. The induction of K299R
PAK1 (Fig. 8A) with reduction of PAK1 kinase activity in
MDA-MB231 (Fig. 8C) cells was associated with a reduction of
in vitro invasive potential (Fig. 8, panel B) and with changes in
cellular shape from a spindle shape to a flatter polygonal shape
(Fig. 8D, -Dox). These morphological changes were clearly ev-
ident after 24 h of kinase dead PAK1 expression and became
more intense at 48 h after induction (Fig. 8D, -Dox). An impor-
tant feature of this system was its reversibility (Fig. 8D, 1Dox).
Similar to our findings presented before in the MDA-MB435
model, a short time induction for 48 h of K299R PAK1 in
MDA-MB231 cells also resulted in two major changes that
concerned (a) the actin conformation and (b) PAK-1 localiza-
tion. First, these cells displayed more stress fibers and a higher
number of mature focal points. Changes in F-actin conforma-
tion were accompanied by co-localization of HA staining to
these cables as well as at the cell periphery (not shown). Sec-
ond, when cells were plated on fibronectin, expression of K299R
PAK1 induced formation of peripheral focal points and bundled
actin fibers with subsequent increased cell spreading (Fig. 9, A,
G, and H). This was very different from the control noninduced
cells, which exhibited persistent ruffle formation (Fig. 9, D, I,
and J, arrows) located close to the less mature, dynamic focal
points (Fig. 9, D, E, and J, arrowheads). These dynamic actin-
containing structures present in the uninduced cells (that do
not express the kinase-defective PAK1) were immunoreactive
to anti-PAK1 antibody. However, no detection of the PAK1 that
might correspond to the focal points, could be seen in these
cells. On the contrary, PAK1 immunoreactivity was changed
when cells were induced to express K299R PAK1, showing a
punctuate distribution at the cell periphery (Fig. 9G, arrows).
Interestingly, this distribution of PAK1 on the peripheral thick
FIG. 5. Kinase-deficient PAK1 mu-
tants increase actin polymerization.
MDA-MB435 cells plated on coverslips
were co-transfected with various PAK1
mutants and a GFP-containing vector,
fixed, and stained for F-actin after 24 h by
using Alexa 546-labeled phalloidin. Cells
were visualized by using an inverted
Zeiss microscope coupled with a charge-
coupled device camera for both GFP
(green) and F-actin (red) reactivity.
FIG. 6. Expression of K299R PAK1 mutant blocks HRG induc-
tion of actin-containing dynamic structures. Cells cultured on
chamber slides were serum-deprived for 24 h, stimulated with 20 ng/ml
HRG (B and D), and fixed after 1 h. Representative examples of the
distribution of F-actin and vinculin in MDA-MB435 K17 (A and B) or
MDA-MB435-CMV (C and D) are shown. Note the appearance of filopo-
dias (shown by arrowheads) as well as a significant dissolution of the
focal points and stress fibers exclusively in HRG-treated MDA-MB435-
CMV cultures (D).
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actin cables was very similar to the distribution of the vinculin-
containing focal points (Fig. 9H, arrowheads). Taken together,
these morphological changes were very similar in both cellular
systems, indicating that the increased cell spreading, changes
in the actin conformation, as well as stabilization of the focal
adhesion complexes may be closely linked with the inactivation
of PAK1 and not with indirect cell culture adaptations.
Effect of K299R PAK1 Expression on Gene Transcription—
The upstream regulators of PAK1, Rac, and Cdc42, have been
shown to stimulate kinase cascades leading to activation of the
JNK/stress-activated protein kinase (11). In addition, a consti-
tutively activated form of PAK1 showed a stimulation of JNK1
activity similar to that obtained with constitutively activated
RacV12 (13). Because stimulation of the AP-1 transcription
factor (a downstream target of JNK) has been shown to be
associated with breast cancer progression (34), we investigated
the influence of a kinase dead PAK1 mutant on the JNK/AP-1
pathway. The low invasive potential of K299R PAK1 trasfec-
tants was maintained after .25 passages (Fig. 10A). As shown
in Fig. 10B, overexpression of K299R in MDA-MB435 cells
(K17 clone) was accompanied by a significant suppression of
JNK activation as determined by subcellular localization of the
phosphorylated JNK using a specific antibody that recognizes
only the phosphorylated forms of JNK-1 or JNK-2. More than
70% of MDA-MB435-K17 cells displayed a low antibody immu-
noreactivity that was predominantly in the cytoplasmic com-
partment, compared with the control MDA-MB435-CMV cells,
which displayed a strong nuclear and cytoplasmic localization
of phosphorylated JNK antibody reactivity. The observed inhi-
bition of JNK activation in K17 cells was confirmed by the
inhibition of JNK kinase activity (Fig. 10C) and by the DNA
binding activity of the AP-1 transcription factor, a downstream
target of JNK (Fig. 10D, lane 4). This was true for the MDA-
MB435-K5 clone but to a lesser extend (Fig. 10D, lane 3). To
understand the function of AP-1 in the action of PAK1, we next
determined whether the K299R PAK1 mutant could modulate
the AP-1 site-driven transcription using a collagenase-lucif-
erase reporter system. As illustrated in Fig. 10E, overexpres-
sion of kinase dead PAK1 resulted in a substantial reduction of
luciferase activity compared with the levels present in control
cells. The observed inhibition of transcription in K17 cells was
because of the lack of AP-1 activation, because deletion of the
AP-1 site resulted in a comparable reduction of luciferase ac-
tivity. PAK1 kinase has been also implicated in the regulation
of the mitogen-activated protein kinase kinase pathway (35),
the effect of K299R PAK1 on the mitogen-activated protein
kinase pathway using immunoblotting with phospho-p42/44
antibody was examined. We failed to observe any difference in
the activation of mitogen-activated protein kinase in K299R
PAK1 expressing cells over the level of vector-transfected cells
(data not shown).
DISCUSSION
Breast cancer is one of the most common malignancies in
western countries. The high mortality rate associated with
breast cancer, however, is related to its ability to metastasize
beyond the mammary gland and invade distant sites, whereas
the primary tumor is small and undetected. Thus, tumor cell
migration/invasion is an important factor in the formation of
FIG. 7. K299R PAK1 mutant promotes persistent F-actin po-
lymerization with the presence of actin-bound TM and CaD.
Cells cultured on chamber slides were fixed after 12 h and co-stained for
F-actin and TM (A and B) or F-actin and CaD (C and D). A separation
of the two channels allows a better distinction of TM distribution (A’
and B’) or of CaD (C’ and D’). A closer view of the region containing the
focal complexes (marked by arrowheads) is shown on the right panels
for TM (E, E’ and F, F’) or for CaD (G, G’ and H, H’). Note the presence
of thick actin-containing cables that are co-stained with TM or CaD in
K17 clones (A and C) compared with the diffuse staining seen in vector-
transfected clones (B and D) and loop-like structures around focal
complexes in K17 transfectants (G, G’).
FIG. 8. The influence of K299R PAK1 expression in MDA-
MD231 model system. A, expression of HA-tagged PAK1 was assayed
using total cell lysates of cells grown in the absence (lane 2) or presence
(lane 3) of doxycyclin. Control lysates containing the HA-tagged PAK1
protein represent the positive control (lane 4). Untransfected parental
MDA-MB231 cells served as a negative control (lane 1). Corresponding
in vitro kinase activity of PAK1 immunoprecipitates from A using
myelin basic protein as a substrate. B, cells were cultured for 24 h in the
absence of doxycyclin before plating them in a Boyden chamber. Cells
with suppressed K299R PAK1 were plated in the same way. Results
represent cell counts after 24 h in 10 different random microscopic
fields of three different wells. Each experiment was repeated at least
three times. C, cell morphological appearance by using low magnifica-
tion phase contrast is shown in uninduced cells (left panel) followed by
48 h of K299R PAK1-induced expression (middle panel) and finally
followed by another 48 h of blocked expression (right panel).
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solid tumors, and it is necessary for their spread to distinct
organs. The progression of breast cancer cells to a more inva-
sive phenotype is believed to be influenced by the migration of
cells from the primary site of tumor, incorporating the ability of
cancer cells to invade through basement membrane and rees-
tablish themselves at distant sites. Because a successful inva-
sion and metastasis of breast tumor is conditional for cell
migration from the primary tumor, cell motility must play a
pivotal role in the development and maintenance of the inva-
sive phenotype of breast cancer cells. Therefore, understanding
cell motility is likely to delineate pathways that may be an
integral part of metastasis. Recently, we showed that PAK1
had a role in cell motility and invasiveness of human breast
cancer cells stimulated by heregulin-b1 (27). To better under-
stand the role of PAK1 in the reorganization of cytoskeleton
components that control motility and in vitro invasiveness of
cells, here we investigated the influence of inhibition of PAK1
activity on the modulation of invasive phenotypes in breast
cancer cells. We utilized two distinct highly invasive breast
cancer cell model systems, one involving stable overexpression
of kinase dead K299R PAK1 in MDA-MB435 cells and another
where there is a conditional regulation of the expression of
K299R PAK1 in MDA-MB231 cells.
The results presented here indicate that overexpression of
kinase dead PAK1 in invasive breast cancer cells leads to
significant morphological changes and reduction of in vitro
invasiveness. Our conclusion that suppression of PAK1 activity
modulated the invasion of breast cancer cells was supported by
the following lines of evidence: (i) expression of K299R PAK1
mutant blocked the transmigration of cells across a porous
membrane, (ii) K299R PAK1 mutant blocked the formation of
ruffles and filopodia induced by other stimuli, (iii) inhibition of
PAK1 by K299R was accompanied by persistent cell spreading
and an increase in the number and maturity of the focal com-
plexes, (iv) K299R expression resulted in the appearance of
thicker actin cables with prolonged co-localization of tropomy-
osin or caldesmon, and (v) the K299R PAK1-mediated blockade
of ruffles and filopodia formation and of migration could not be
reversed by HRG. Taken together, these data provide evidence
that PAK1-regulated reorganization of cytoskeleton structures
may be required to maintain the invasive phenotype of breast
cancer cells.
Among the various pathways leading to actin reorganization,
the Rho subfamily of the small GTPases, cdc42 and Rac1, has
been implicated in the regulation of morphology and motility of
mammalian cells. Recent studies have identified the PAKs as a
target of activated GTPases, as activation of PAK1 has been
shown to result in the phenotypic changes reminiscent of those
produced by Rac and/or cdc42 (36). Furthermore, a role of PAK
in promoting cell migration has been also suggested by the
physical interaction between PAK1 and actin in response to
upstream stimuli (7, 27). The propensity of malignant breast
cancer cells to invade must depend on their ability to migrate
from the primary tumor site. Our observation that kinase dead
PAK1 predominantly localizes to the fairly stable focal points
supports a role for PAK1 in promoting cell motility, probably by
its known function to dissolve the focal adhesions (31). How-
ever, because the K299R kinase dead PAK1 mutant still con-
tains binding sites for Rac/cdc42, which are known to promote
phenotypic changes similar to those caused by PAK1, it is
possible that the observed effects could have been reflections of
ineffective transduction of Rac/cdc42 signals. However, trans-
fection of double PAK1 mutant H83, 86L, K299R (which has
mutation in CRIB site and PAK1 kinase domain) also demon-
strated increased actin bundling, cell spreading,and stabiliza-
tion of focal points. Furthermore, expression of the PAK1 au-
toinhibitory domain (PAK 83–149) also exhibited changes in
cell shape (to a lesser degree) similar to K299R PAK1. Taken
together, these results indicated that PAK1 kinase activity is
involved in the cell shape changes, increased focal points and
F-actin bundling in MDA-MB-435 cells. These findings suggest
a role of PAK1 kinase activity in the motility of human epithe-
lial cancer cells.
Recently, kinase active PAK1 has been shown to cause ex-
cessive dissolution of focal adhesions and stress fibers (9, 31)
and directional haptotaxis in fibroblasts (8). Another notable
finding in this study was the essential role of PAK1 in actin
dynamics, as catalytically inactive PAK1 may impair the for-
mation of dynamic actin-containing structures necessary for
cell migration and the formation of the focal points. Some of the
possible mechanisms for the observed decreased migration po-
tential may include a change in F-actin conformation induced
by increasing the actin bundling or stability or blocking the
F-actin capping. Caldesmon and tropomyosin are two major
actin-binding proteins that can modulate the stability of actin
filament (32). It has been shown that caldesmon coupled with
tropomyosin not only blocks the binding of human fascin to
actin (37) but also dissociates fascin from actin (38), implying
that caldesmon together with tropomyosin regulates the as-
sembly of actin bundles. There is also an increasing body of
evidence showing that caldesmon stabilizes microfilaments in
nonmuscle cells (33), probably by increasing actin binding of
FIG. 9. K299R PAK1 expression induces focal adhesion com-
plexes and F-actin thick cables formation and affects PAK1
distribution. Cells cultured on fibronectin-coated chamber slides were
fixed after 12 h and co-stained for F-actin and vinculin (A, D, H, and J)
and for F-actin and PAK1 (G and J). Representative examples of vin-
culin distribution in K299R-induced expression (A and H) or PAK1 (G)
as well as in uninduced cells (D and J) and of PAK1 (I) are shown. Blue
color, when showed, corresponds to the DAPI-stained nuclei.
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tropomyosin (39, 40). In nonmuscle cells, caldesmon, an actin-
binding protein, may have important regulatory functions in
cell motility, analogous to those suggested for the regulation of
smooth muscle contraction. Dissociation of caldesmon from
microfilaments may destabilize the structure of microfila-
ments. Something similar may happen during cell motility
where there is a dramatic cytoskeleton rearrangement of the
stress fibers connecting the cells in the focal points (attachment
and spreading) with subsequent dissolution and reformation of
more dynamic actin-containing structures such as ruffles and
lamellopodias. It remains to be established how PAK1 contrib-
utes to the interaction of the actin with tropomyosin and
caldesmon. Several substrates have been recently found to be
phosphorylated by different members of the PAK family with
functional impact on the contraction properties of actin fila-
ments. More contraction of actin filaments (stress fibers)
causes less motility in nonmuscle cells (41). Recent studies
have shown that PAK3 is able to phosphorylate caldesmon
independently of the induction of muscle contraction (42). Ev-
idence also suggests that myosin light chain kinase binds to
cellular actin filaments and is localized to actinomyosin-con-
taining stress fibers in nonmuscle cells. In a very elegant study
on smooth muscle cells that used GFP-labeled myosin light
chain kinase the filament-bound kinase was shown to be suf-
ficient for Ca21-dependent phosphorylation of myosin regula-
tory light chain and contraction of stress fiber (43). One of the
recently identified PAK1 substrates is indeed myosin light
chain kinase, and its phosphorylation by PAK1 in vitro and in
vivo was shown to decrease myosin light chain activity, leading
to a decrease in cell spreading and thus less actin-myosin
contraction (44). Our finding that the kinase dead mutant
K299R PAK1 increased the cell spreading and the appearance
of stress fibers suggests a possible role of PAK1 in microfila-
ments remodeling via the myosin light chain kinase pathway.
However our results do not distinguish if these effects are
because of the increase in actin-myosin contraction, stabiliza-
tion of actin by actin-binding proteins, or both. Future studies
will be needed to determine the precise nature of interplay
between Rac, cdc42, and RhoA effectors in these processes.
The evidence that overexpression of the kinase dead K299R
PAK1 mutant in breast cancer cells has the capacity to inhibit
the DNA binding activity and of AP-1-dependent transcription
in vivo is of special interest, as it strongly suggests that PAK1-
induced signaling may modulate the expression of genes, such
as matrix metalloproteinases (45), which are relevant for inva-
sion via the AP-1-dependent pathway. This hypothesis is fur-
ther supported by our preliminary studies showing a reduction
of gelatinolytic activity in the conditioned medium that had
K299R PAK1-overexpressing MDA-MB435 cells (data not
shown). Because PAK1 is considered to be an activator of JNK
and p38 MAPK (46), it is possible that the JNK/p38 down-
stream events influence the expression of gene products with
functions in motility/invasion of breast cancer cells. Taken
together, our findings of regulation of actin reorganization, cell
migration and invasion, and gene regulation functions of breast
cancer cells by PAK1 open a new avenue of investigation closely
FIG. 10. Effect of K299R PAK1 expression on JNK/AP-1 pathway. A, invasive potential of two K299R PAK1-expressing clones (K17 and K5)
compared with mock-transfected cells (CMV-4). B, MDA-MB435 expressing the K299R PAK1 or mock-transfected cells were plated in chamber
slides, stained for the phosphorylated form of JNK-1 and -2, and analyzed by confocal microscopy. Representative intracytoplasmic and nuclear
distribution for MDA-MB435-CMV (left panel) or faint intracytoplasmic for MDA-MB435-K17 (right panel) is shown. C, JNK immunoprecipitates
from total cell lysates were assayed for the JNK kinase activity by using c-Jun-glutathione S-transferase as a substrate. D, cell nuclear extracts
from two controls (MDAMB435 and MDAMB-CMV) or two K299R PAK1-expressing cell lines (K5 and K17) were incubated with 32P-labeled AP-1
DNA probe, and the AP-1 binding activity was measured by electrophoretic mobility shift assay. E, MDA-MB435-CMV and MDA-MB435-K17 were
transiently transfected with a 270 collagenase promoter containing a functional AP-1 binding site (wtAP-1) and a 260 collagenase promoter
containing one deletion of the AP-1 binding site (DAP-1) and assayed for the luciferase activity. The results, corrected for the transfection efficiency
and for protein levels, represent the relative luciferase units.
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linking PAK1, cytoskeleton-signaling, transcription of genes
involved in metastasis, and breast cancer invasiveness. In ad-
dition, our present finding may lead to strategies targeting
PAK1 as a potential inhibitor of invasion and metastasis of
breast cancer cells.
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